imfinzi-infusion-conc-vial-120-mg-2-4-ml

Imfinzi infusion conc (vial) 120 mg/2.4 mL (120 mg/2.4 mL)

Manufacturer: AstraZeneca

Distributor: Zuellig Pharma

Contents: durvalumab

MIMS Class: Cancer Immunotherapy

Form: Vial

Shape: Undefined

Sign up for Free to Continue Reading

Continue with Google

Sign up with email

Already a member? Sign in